BioAdaptives Launches Nighttime Supplement Targeting Sleep and Cognitive Recovery
BioAdaptives launches MyndRenew, a nighttime supplement to support sleep and brain recovery, addressing the widespread issue of insufficient sleep among U.S. adults.
BioAdaptives, Inc. (OTC: BDPT) has announced the launch of MyndRenew(TM), a nighttime dietary supplement designed to support sleep quality and the brain’s overnight recovery processes. The product aims to address what the company describes as a critical gap in cognitive health, given that more than one-third of U.S. adults report insufficient sleep, according to the press release.
MyndRenew is part of the MyndSystem(TM) platform, which targets full 24-hour cognitive support. The platform includes both daytime and nighttime formulations tailored to distinct physiological demands across the daily cycle. MyndRenew complements the company’s existing daytime product, MyndMed(TM), creating a comprehensive approach to cognitive health.
The formulation of MyndRenew includes 13 ingredients selected from published scientific literature. Key components include magnesium glycinate, apigenin, PEA (palmitoylethanolamide), and lion’s mane mushroom extract. These ingredients are aimed at supporting sleep pathways, cellular repair, stress regulation, and neuroprotection, according to the company.
The launch of MyndRenew is significant because it addresses a widespread health concern: insufficient sleep. The Centers for Disease Control and Prevention (CDC) has previously noted that more than one-third of U.S. adults report getting less than the recommended seven hours of sleep per night. Poor sleep is linked to a range of health issues, including cognitive decline, impaired immune function, and increased risk of chronic diseases. By targeting the brain’s overnight recovery processes, BioAdaptives is positioning MyndRenew to potentially help mitigate some of these risks.
BioAdaptives focuses on developing science-based health and wellness products for human and animal use. The company’s formulations are rooted in published research across nutrition, adaptogens, and cellular health, with an emphasis on supporting normal physiological function. The MyndSystem platform represents a strategic expansion into cognitive health, a growing market as consumers increasingly seek products to enhance mental performance and overall well-being.
For more information about BioAdaptives and its products, visit the company’s website at www.bioadaptives.com. To view the full press release, visit https://ibn.fm/jubib.